While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

For those who are uninsured or under-insured, CDPH will have vaccine at its three CDPH Immunization Clinics. Walk-ins are ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

A factor that has changed over time is hospitalization due to severe COVID infections. On Aug. 1, the statewide seven-day ...